The volume of distribution of alfuzosin is 2.5 L/kg, and 90% of each dose is protein bound. Because the volume of distribution of alfuzosin is lower in some elderly patients, the initial dose in these ...

The Food and Drug Administration (FDA) is reviewing an ER formulation of alfuzosin hydrochloride 10 mg for once-daily administration for treatment of symptomatic BPH. The IR and twice-daily ER ...

Alfuzosin is available as a generic drug and as a brand-name drug. Brand name: Uroxatral. Alfuzosin only comes as an extended-release oral tablet. Alfuzosin is used to treat benign prostatic ...

This randomized, double-blind, placebo-controlled study was conducted at 52 sites in the United States from 10 January 2003 to 18 August 2003. An amendment to the original study protocol, made on 22 ...

Wockhardt announced that it has received final approval from the FDA for Alfuzosin HCl Extended-Release Tablets, the generic version of Sanofi-Aventis‘ Uroxatral. Alfuzosin HCl is an α 1-blocker ...

Mylan has begun shipment of Alfuzosin HCl extended-release tablets, the generic version of Uroxatral (sanofi aventis), a treatment for signs and symptoms of benign prostatic hyperplasia. Alfuzosin HCl ...

PARSIPPANY, N.J. and MUMBAI, India, Aug. 14, 2012 /PRNewswire/ -- Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA ...

MUMBAI, Nov 19 (Reuters) - The U.S. Food and Drug Administration has tentatively approved Aurobindo Pharma Ltd's alfuzosin hydrochloride extended release tablets, the regulator's website showed. The ...

Unichem Laboratories Ltd has informed BSE regarding a Press Release dated January 29, 2016 titled "Unichem Laboratories receives Final ANDA approval from USFDA for Alfuzosin Hydrochloride ...

Unichem Laboratories Limited has been granted Certificate of suitability to European Pharmacopeia (CEP) by European Directorate for the Quality of Medicines and Healthcare (EDQM) for Alfuzosin ...